Latest News and Press Releases
Want to stay updated on the latest news?
-
Kuntarahoitus OyjPörssitiedote06.11.2025 klo 10.00 Kuntarahoitus Oyj:n ennenaikaisesti eräännyttämä joukkovelkakirja on poistettu pörssilistalta Kuntarahoitus Oyj ilmoitti 22.10.2025...
-
Municipality Finance PlcStock exchange release 6 November 2025 at 10:00 am (EET) The notes redeemed by Municipality Finance have been removed from trading at Nasdaq Helsinki On 22 October 2025...
-
Luxembourg, November 6, 2025 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the "Group") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world’s leading...
-
New analysis confirms reductions in blood pressure and albuminuria by aprocitentan in patients with true resistant hypertension and high cardiovascular risk – including chronic kidney disease ...
-
Pratteln, Schweiz, 5. November 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt das Closing der Lizenzgebührenvereinbarung über 13 Millionen US-Dollar bekannt, die erstmals im September 2025...
-
Pratteln, Switzerland, November 5, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the closing of a USD 13 million royalty monetization agreement, first announced in September 2025, to support...
-
GRAND-LANCY, Switzerland, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), a global leader in banking technology, today announced it has been Certified™ by Great Place To Work® in 15 locations...
-
Ad-hoc-Mitteilung gemäss Art. 53 KR Vergleichbare Langzeitwirksamkeit wie bei der Standardtherapie mit Kortikosteroiden über 5 Jahre Normales Wachstum bleibt erhalten, im Gegensatz zur...
-
Ad hoc announcement pursuant to Art. 53 LR Comparable long-term effectiveness to standard of care corticosteroids over 5 years Normal growth maintained, in contrast to growth suppression commonly...
-
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 04, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to...